Закс Л. Статистическое оценивание. М.: Cтатистика; 1976. 118 с.
Руководство по экспериментальному (доклиническому) изучению новых фармацевтических веществ. Под ред. чл.-корр. РАМН Хабриева Р.У. М.: Медицина; 2005. 832 с.
Chandrasekaran A., Srinivasan A., Raman R., et al. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat. Biotechnol. 2008; 26:107-13.
Chandrasekaran A., Srinivasan A., Raman R., et al. Quantitative biochemical rationale for differences in transmissibility of 1918 pandemic influenza A viruses. Proc. Natl. Acad. Sci. U.S.A. 2008; 105:2800-5.
Garten R.J., Davis C. T., Russell C.A. et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science, sciencexpress. 2009; 1126/.1176225:1-10.
Matrosovich M., Tuzikov A., Bovin N., et al. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J. Virol. 2000; 74: 8502-12.
Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 2009; 360:2605-15.
Shinde V., Bridges C.B., Uyeki T.M., et al. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N. Engl. J. Med. 2009; 360:1-10.
Zimmer S.M., Burke D.S. Historical perspective - emergence of influenza A (H1N1) viruses. N. Engl. J. Med. 2009; 361: 279-85.